Recruitment for the SWEET Study is now closed.

Watch our recruitment animation below.

Eligibility Criteria:

• Are Aged 18+
• Are Female
• Have had a diagnosis of ER positive invasive breast cancer, stages 1-3, treated with curative intent
• Are within 3 months of first oral AET prescription (tamoxifen or aromatase inhibitor)
• Have completed surgery to remove breast cancer
• Have completed chemotherapy (if applicable)
• Can access the internet and have an email address; and
• Are willing to receive a support package with a web-based component.

To contact the SWEET research team for general queries about SWEET you can contact the team on: SWEET@warwick.ac.uk